Background: In mastocytosis, the skin is almost invariably involved, and cutaneous symptoms deeply affect patients' quality of life. Methods: A retrospective observational analysis of patients affected by cutaneous mastocytosis (CM) and indolent systemic mastocytosis (ISM) treated with phototherapy/photochemotherapy (PUVA or NB-UVB) has been conducted. For each patient, total numbers of PUVA or NB-UVB exposures, the cumulative UV dose (J/cm2), serum tryptase profile, and pruritus, before and after treatment, according to the visual analogue scale (VAS) were considered. Skin lesions of each patient were assessed, before and after treatment, according to a cutaneous scale score. Results: Twenty patients affected by CM and ISM were studied; in particular, 10 patients received NB-UVB therapy, and other 10 patients received PUVA. A statistically significant mean reduction of pruritus in both groups (P < 0.01) was observed. The number of treatments necessary to obtain symptom relief was significantly lower in the PUVA group, but the mean exposure dose was significantly higher, if compared to the NB-UVB group. Serum tryptase levels showed a downward trend. The cutaneous score improved in both groups. Limitations: This study was a retrospective study with a small sample size and without a control group. Conclusion: This work provides evidence that both NB-UVB and PUVA represent a safe and useful second-line therapy of the cutaneous symptoms in mastocytosis.

Narrow-band UVB phototherapy and psoralen–ultraviolet A photochemotherapy in the treatment of cutaneous mastocytosis: a study in 20 patients / Brazzelli, Valeria; Grassi, Sara; Merante, Serena; Grasso, Vincenzo; Ciccocioppo, Rachele; Bossi, Grazia; Borroni, Giovanni. - In: PHOTODERMATOLOGY, PHOTOIMMUNOLOGY & PHOTOMEDICINE. - ISSN 0905-4383. - 32:5-6(2016), pp. 238-246. [10.1111/phpp.12248]

Narrow-band UVB phototherapy and psoralen–ultraviolet A photochemotherapy in the treatment of cutaneous mastocytosis: a study in 20 patients

Grassi, Sara;
2016

Abstract

Background: In mastocytosis, the skin is almost invariably involved, and cutaneous symptoms deeply affect patients' quality of life. Methods: A retrospective observational analysis of patients affected by cutaneous mastocytosis (CM) and indolent systemic mastocytosis (ISM) treated with phototherapy/photochemotherapy (PUVA or NB-UVB) has been conducted. For each patient, total numbers of PUVA or NB-UVB exposures, the cumulative UV dose (J/cm2), serum tryptase profile, and pruritus, before and after treatment, according to the visual analogue scale (VAS) were considered. Skin lesions of each patient were assessed, before and after treatment, according to a cutaneous scale score. Results: Twenty patients affected by CM and ISM were studied; in particular, 10 patients received NB-UVB therapy, and other 10 patients received PUVA. A statistically significant mean reduction of pruritus in both groups (P < 0.01) was observed. The number of treatments necessary to obtain symptom relief was significantly lower in the PUVA group, but the mean exposure dose was significantly higher, if compared to the NB-UVB group. Serum tryptase levels showed a downward trend. The cutaneous score improved in both groups. Limitations: This study was a retrospective study with a small sample size and without a control group. Conclusion: This work provides evidence that both NB-UVB and PUVA represent a safe and useful second-line therapy of the cutaneous symptoms in mastocytosis.
2016
cutaneous mastocytosis; NB-UVB phototherapy; PUVA photochemotherapy; systemic mastocytosis; Adult; Female; Ficusin; Humans; Male; Mastocytosis, Cutaneous; Middle Aged; PUVA Therapy; Immunology and Allergy; Immunology; Radiology, Nuclear Medicine and Imaging; 2708
01 Pubblicazione su rivista::01a Articolo in rivista
Narrow-band UVB phototherapy and psoralen–ultraviolet A photochemotherapy in the treatment of cutaneous mastocytosis: a study in 20 patients / Brazzelli, Valeria; Grassi, Sara; Merante, Serena; Grasso, Vincenzo; Ciccocioppo, Rachele; Bossi, Grazia; Borroni, Giovanni. - In: PHOTODERMATOLOGY, PHOTOIMMUNOLOGY & PHOTOMEDICINE. - ISSN 0905-4383. - 32:5-6(2016), pp. 238-246. [10.1111/phpp.12248]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1109794
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 28
social impact